Expertise in Blood and Bone Marrow Transplant (BMT)
The Stanford Blood and Marrow Transplant Program combines 25 years
of treatment expertise, state-of-the-art research and comprehensive
support services to provide the best possible outcomes. Offering
treatment for malignant and non-malignant diseases, including
lymphoma, myeloma, leukemia, myelodysplastic syndromes, and selected
solid tumors, our program strives to integrate each patient into
normal, everyday life.